- Home
- TTI vs XERS Comparison
TTI vs XERS Comparison
Compare TTI & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTI
- XERS
- Stock Information
- Founded
- TTI 1981
- XERS 2005
- Country
- TTI United States
- XERS United States
- Employees
- TTI N/A
- XERS N/A
- Industry
- TTI Oil & Gas Production
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- TTI Energy
- XERS Health Care
- Exchange
- TTI Nasdaq
- XERS Nasdaq
- Market Cap
- TTI 458.7M
- XERS 500.2M
- IPO Year
- TTI 1990
- XERS 2018
- Fundamental
- Price
- TTI $3.84
- XERS $3.61
- Analyst Decision
- TTI Strong Buy
- XERS Buy
- Analyst Count
- TTI 4
- XERS 3
- Target Price
- TTI $7.13
- XERS $4.87
- AVG Volume (30 Days)
- TTI 829.8K
- XERS 1.5M
- Earning Date
- TTI 02-25-2025
- XERS 11-08-2024
- Dividend Yield
- TTI N/A
- XERS N/A
- EPS Growth
- TTI N/A
- XERS N/A
- EPS
- TTI 0.01
- XERS N/A
- Revenue
- TTI $617,733,000.00
- XERS $187,361,000.00
- Revenue This Year
- TTI N/A
- XERS $24.27
- Revenue Next Year
- TTI $12.65
- XERS $18.57
- P/E Ratio
- TTI $70.06
- XERS N/A
- Revenue Growth
- TTI N/A
- XERS 22.72
- 52 Week Low
- TTI $2.68
- XERS $1.69
- 52 Week High
- TTI $5.08
- XERS $3.87
- Technical
- Relative Strength Index (RSI)
- TTI 59.56
- XERS 60.10
- Support Level
- TTI $3.38
- XERS $3.27
- Resistance Level
- TTI $3.60
- XERS $3.51
- Average True Range (ATR)
- TTI 0.18
- XERS 0.16
- MACD
- TTI 0.02
- XERS -0.00
- Stochastic Oscillator
- TTI 94.44
- XERS 100.00
About TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Division provides onshore oil and gas operators with comprehensive water management services. The company derives maximum revenue from United states.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.